Cargando…
Insights from advancements and pathbreaking research on the minimally invasive treatment of atrial fibrillation
Atrial fibrillation (AF) remains the most common cardiac arrhythmia with increasing prevalence in developed and aging countries. Pharmacological antiarrhythmic therapy has low effectiveness and is limited by its toxicity. Developed in 1987 by James Cox surgical ablation of AF called MAZE procedure w...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
AME Publishing Company
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8024848/ https://www.ncbi.nlm.nih.gov/pubmed/33841986 http://dx.doi.org/10.21037/jtd-20-1876 |